BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 19348861)

  • 21. Obesogens and Obesity: State-of-the-Science and Future Directions Summary from a Healthy Environment and Endocrine Disruptors Strategies Workshop.
    Heindel JJ; Alvarez JA; Atlas E; Cave MC; Chatzi VL; Collier D; Corkey B; Fischer D; Goran MI; Howard S; Kahan S; Kayhoe M; Koliwad S; Kotz CM; La Merrill M; Lobstein T; Lumeng C; Ludwig DS; Lustig RH; Myers P; Nadal A; Trasande L; Redman LM; Rodeheffer MS; Sargis RM; Stephens JM; Ziegler TR; Blumberg B
    Am J Clin Nutr; 2023 Jul; 118(1):329-337. PubMed ID: 37230178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Environmental Obesogens and Their Impact on Susceptibility to Obesity: New Mechanisms and Chemicals.
    Egusquiza RJ; Blumberg B
    Endocrinology; 2020 Mar; 161(3):. PubMed ID: 32067051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endocrine disrupters as obesogens.
    Grün F; Blumberg B
    Mol Cell Endocrinol; 2009 May; 304(1-2):19-29. PubMed ID: 19433244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of In Vitro Models for Studying the Mechanisms Underlying the Obesogenic Action of Endocrine-Disrupting Chemicals (EDCs) as Food Contaminants-A Review.
    Kowalczyk M; Piwowarski JP; Wardaszka A; Średnicka P; Wójcicki M; Juszczuk-Kubiak E
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obesogens in Adolescence: Challenging Aspects and Prevention Strategies.
    Nicolaou M; Toumba M; Kythreotis A; Daher H; Skordis N
    Children (Basel); 2024 May; 11(5):. PubMed ID: 38790597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is Technical-Grade Chlordane an Obesogen?
    Silva JF; Moreira BP; Rato L; de Lourdes Pereira M; Oliveira PF; Alves MG
    Curr Med Chem; 2021; 28(3):548-568. PubMed ID: 31965937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Environmental estrogens and obesity.
    Newbold RR; Padilla-Banks E; Jefferson WN
    Mol Cell Endocrinol; 2009 May; 304(1-2):84-9. PubMed ID: 19433252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obesogenic Endocrine Disrupting Chemicals: Identifying Knowledge Gaps.
    Veiga-Lopez A; Pu Y; Gingrich J; Padmanabhan V
    Trends Endocrinol Metab; 2018 Sep; 29(9):607-625. PubMed ID: 30017741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Environmental estrogens shape disease susceptibility.
    Zheng R; Zhang Y; Cheng S; Xiao T
    Int J Hyg Environ Health; 2023 Apr; 249():114125. PubMed ID: 36773581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From a toxin to an obesogen: a review of potential obesogenic roles of acrylamide with a mechanistic approach.
    Buyukdere Y; Akyol A
    Nutr Rev; 2023 Dec; 82(1):128-142. PubMed ID: 37155834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Developmental exposure to endocrine disruptors and the obesity epidemic.
    Newbold RR; Padilla-Banks E; Snyder RJ; Phillips TM; Jefferson WN
    Reprod Toxicol; 2007; 23(3):290-6. PubMed ID: 17321108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogenic compounds as exogenous modulators of physiological functions in molluscs: Signaling pathways and biological responses.
    Balbi T; Ciacci C; Canesi L
    Comp Biochem Physiol C Toxicol Pharmacol; 2019 Aug; 222():135-144. PubMed ID: 31055067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of nutrition and environmental endocrine disrupting chemicals during the perinatal period on the aetiology of obesity.
    Heindel JJ; vom Saal FS
    Mol Cell Endocrinol; 2009 May; 304(1-2):90-6. PubMed ID: 19433253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differing species responsiveness of estrogenic contaminants in fish is conferred by the ligand binding domain of the estrogen receptor.
    Miyagawa S; Lange A; Hirakawa I; Tohyama S; Ogino Y; Mizutani T; Kagami Y; Kusano T; Ihara M; Tanaka H; Tatarazako N; Ohta Y; Katsu Y; Tyler CR; Iguchi T
    Environ Sci Technol; 2014 May; 48(9):5254-63. PubMed ID: 24689804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible relationship between endocrine disrupting chemicals and hormone dependent gynecologic cancers.
    Dogan S; Simsek T
    Med Hypotheses; 2016 Jul; 92():84-7. PubMed ID: 27241264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of Epigenetics in the Latent Effects of Early Life Exposure to Obesogenic Endocrine Disrupting Chemicals.
    Stel J; Legler J
    Endocrinology; 2015 Oct; 156(10):3466-72. PubMed ID: 26241072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endocrine-disrupting chemicals and the regulation of energy balance.
    Nadal A; Quesada I; Tudurí E; Nogueiras R; Alonso-Magdalena P
    Nat Rev Endocrinol; 2017 Sep; 13(9):536-546. PubMed ID: 28524168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Environmental endocrine disruptors and obesity.
    Karoutsou E; Polymeris A
    Endocr Regul; 2012 Jan; 46(1):37-46. PubMed ID: 22329821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. History of the Obesogen Field: Looking Back to Look Forward.
    Heindel JJ
    Front Endocrinol (Lausanne); 2019; 10():14. PubMed ID: 30761083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Endocrine Society Centennial: No Longer a Surprise: Estrogenic Chemicals in a Multitude of Places.
    Rissman EF
    Endocrinology; 2016 Aug; 157(8):2969-71. PubMed ID: 27477860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.